Gilead Sciences
GILD
#105
Rank
A$262.13 B
Marketcap
A$211.41
Share price
0.20%
Change (1 day)
19.20%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2026 (TTM): -A$2.5 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are A$30.45 Billion. In 2025 the company made an earning of A$14.07 Billion, an increase over its 2024 earnings that were of A$0.99 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$2.5 Billion-117.72%
2025 A$14.07 B1319.86%
2024 A$0.99 B-89.94%
2023 A$9.85 B17.97%
2022 A$8.35 B-29.77%
2021 A$11.89 B395.99%
2020 A$2.39 B-67.66%
2019 A$7.41 B-33.84%
2018 A$11.20 B-42.35%
2017 A$19.43 B-20.87%
2016 A$24.56 B-21.06%
2015 A$31.11 B45.8%
2014 A$21.34 B253.01%
2013 A$6.04 B16.51%
2012 A$5.18 B-1.07%
2011 A$5.24 B-6.71%
2010 A$5.62 B11.75%
2009 A$5.03 B29.5%
2008 A$3.88 B19.11%
2007 A$3.26 B-455.74%
2006 -A$0.92 Billion-154.93%
2005 A$1.66 B76.99%
2004 A$0.94 B-266.16%
2003 -A$0.57 Billion-638.24%
2002 A$0.10 B31.5%
2001 A$80.19 M-242.15%
2000 -A$56.42 Million-40.2%
1999 -A$94.35 Million31.85%
1998 -A$71.56 Million8.73%
1997 -A$65.81 Million27.22%
1996 -A$51.73 Million
1994 -A$49.29 Million26.57%
1993 -A$38.94 Million46.49%
1992 -A$26.59 Million362.5%
1991 -A$5.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.65 B-1,440.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$9.92 B-453.30%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$12.49 B-544.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$48.27 B-1,818.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.78 B-626.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$1.45 B-151.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.66 B-159.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$7.24 B-358.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$11.04 B-493.35%๐Ÿ‡บ๐Ÿ‡ธ USA